The Effect of Fish Oils With Dairy or Plant Based Lipids on Mitochondrial and Physical, and Cognitive Function, in Elderly Humans
NCT ID: NCT04194983
Last Updated: 2020-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
25 participants
INTERVENTIONAL
2019-12-11
2020-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fish oils and dairy fats
Fish oils and dairy fat
12-weeks, 3x per day
Fish oils and plant fats
Fish oils and plant fat
12-weeks, 3x per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fish oils and dairy fat
12-weeks, 3x per day
Fish oils and plant fat
12-weeks, 3x per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caucasian;
* Age ≥ 65 years;
* BMI ≥ 20 kg/m2 ≤ 30 kg/m2;
* Normal physical activity levels: maximum of 1 hour per week engagement in structured exercise of moderate to high intensity;
* Subject should be in sufficient health to participate in the experiments, to be judged by the site-specific responsible physician, based on the subject's medical history.
Exclusion Criteria
* Excessive alcohol use (greater than 20g per day) and/or drug abuse;
* Subjects with diagnosed diabetes mellitus type 2;
* Significant food allergies or intolerances concerning the study products, e.g. cow's milk protein allergy
* Participation in another biomedical study possibly interfering with the study results within 1 month before the first study visit;
* Medication use e.g. antithrombotic medications known to hamper subject's safety during the study procedures;
* Subjects habitually taking fish oil supplements within 3-months of the initial study visit or habitually taking supplements that are likely to affect the main study outcomes;
* Subjects who do not want to be informed about unexpected medical findings;
* Subjects who do not want their treating physician to be informed about unexpected medical findings;
* Inability to participate and/or complete the required measurements
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wageningen University and Research
OTHER
Netherlands Organisation for Scientific Research
OTHER_GOV
Top Institute Food and Nutrition
OTHER
Maastricht University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Schrauwen, PhD
Role: PRINCIPAL_INVESTIGATOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wageningen University and Research
Wageningen, Gelderland, Netherlands
Maastricht University
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL68966.068.19
Identifier Type: -
Identifier Source: org_study_id